Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Valaciclovir

Drug Profile

Valaciclovir

Alternative Names: 256U; 256U87; BW 256; BW 256U; Talavir; Valacyclovir; Valherpes; Valtrex; Vapridol; Virval; Zelitrex

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GlaxoSmithKline; GSK
  • Class Antivirals; Branched-chain amino acids; Essential amino acids; Hypoxanthines; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cytomegalovirus infections; Herpes simplex virus infections; Herpes zoster; Herpesvirus infections

Most Recent Events

  • 03 Jun 2015 No recent reports on development identified - Phase-III for Herpes simplex virus infections (Prevention) in Japan (PO)
  • 01 Mar 2015 GlaxoSmithKline completes a phase II trial for Hepatitis C in USA (NCT01580995)
  • 13 Dec 2013 Generic equivalent available in Japan for Viral infections
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top